Gesundheitswissenschaftliches Journal

  • ISSN: 1108-7366
  • H-Index der Zeitschrift: 51
  • Zitierbewertung der Zeitschrift: 10.69
  • Journal-Impact-Faktor: 9.13
Indiziert in
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • CINAHL Komplett
  • Scimago
  • Elektronische Zeitschriftenbibliothek
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • EMCare
  • OCLC – WorldCat
  • Kommission für Universitätsstipendien
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • Google Scholar
  • SHERPA ROMEO
  • Geheime Suchmaschinenlabore
Teile diese Seite

Abstrakt

Cell Therapy Advancements for Immunological Conditions

Odam SG*, Shippman J

Cell therapy has emerged as a ground-breaking approach in the field of immunology, presenting new opportunities for the treatment of various immunological conditions. This innovative therapeutic strategy involves utilizing living cells to enhance or suppress the immune response, depending on the specific disease being targeted. In this abstract, we explore the applications of cell therapy in immunological disorders, including autoimmune diseases, cancer immunotherapy, immunodeficiencies, allergic disorders, and transplantation. Specifically, we discuss the use of regulatory T-cells (Tregs) to suppress autoimmunity, chimeric antigen receptor T-cell (CAR-T) therapy for cancer treatment, and hematopoietic stem cell transplantation (HSCT) for immunodeficiencies. Furthermore, we highlight the challenges associated with cell therapy, including safety concerns, personalized approaches, cost, and long-term efficacy. Despite these challenges, cell therapy holds great promise, paving the way for transformative advancements in immunology and offering hope for improved treatment outcomes and potential cures for patients with immunological conditions. Continued research and development in this area will undoubtedly shape the future of immunology and pave the way for personalized, effective, and accessible cell-based treatments.

Keywords

Cell therapy; Immunology; Autoimmune disorders; Cancer immunotherapy; Regulatory T-Cells; Chimeric antigen receptor T-Cells (CAR-T); Hematopoietic stem cell transplantation (HSCT); Immunodeficiency

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert